{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:21:18Z","timestamp":1792002078184,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CTSA","award":["UL1 TR000142"],"award-info":[{"award-number":["UL1 TR000142"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA033312-03"],"award-info":[{"award-number":["K12DA033312-03"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01 DA034678"],"award-info":[{"award-number":["R01 DA034678"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K01-MH103080"],"award-info":[{"award-number":["K01-MH103080"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23MH102129-03"],"award-info":[{"award-number":["K23MH102129-03"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10461-016-1612-6","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T10:41:32Z","timestamp":1480329692000},"page":"1025-1033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Primary Care Physicians\u2019 Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs"],"prefix":"10.1007","volume":"21","author":[{"given":"E. Jennifer","family":"Edelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Berkenblit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazo","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karran","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette M.","family":"Tetrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minesh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oni","family":"Blackstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"issue":"9651","key":"1612_CR1","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733\u201345.","journal-title":"Lancet."},{"issue":"2","key":"1612_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11904-010-0043-7","volume":"7","author":"SA Strathdee","year":"2010","unstructured":"Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV\/AIDS Rep. 2010;7(2):99\u2013106.","journal-title":"Curr HIV\/AIDS Rep."},{"key":"1612_CR3","unstructured":"Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007\u20132010. 2012, Dec 2012 Report No."},{"issue":"1","key":"1612_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","volume":"25","author":"GJ MacArthur","year":"2014","unstructured":"MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34\u201352.","journal-title":"Int J Drug Policy"},{"key":"1612_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004145.pub4","author":"L Gowing","year":"2011","unstructured":"Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011. doi:\n                    10.1002\/14651858.CD004145.pub4\n                    \n                  .","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"1612_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/QAD.0000000000001039","volume":"30","author":"DC Des Jarlais","year":"2016","unstructured":"Des Jarlais DC, Kerr T, Carrieri P, Feelemyer J, Arasteh K. HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks. AIDS. 2016;30(6):815\u201326.","journal-title":"AIDS"},{"key":"1612_CR7","unstructured":"WHO, UNODC, UNAIDS Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. 2012 Revision"},{"key":"1612_CR8","doi-asserted-by":"publisher","first-page":"18899","DOI":"10.7448\/IAS.17.1.18899","volume":"17","author":"DJ Escudero","year":"2014","unstructured":"Escudero DJ, Lurie MN, Kerr T, Howe CJ, Marshall BD. HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research. J Int AIDS Soc. 2014;17:18899.","journal-title":"J Int AIDS Soc."},{"issue":"9883","key":"1612_CR9","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083\u201390.","journal-title":"Lancet"},{"issue":"7","key":"1612_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/QAD.0000000000000613","volume":"29","author":"M Martin","year":"2015","unstructured":"Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 2015;29(7):819\u201324.","journal-title":"AIDS."},{"key":"1612_CR11","unstructured":"US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142014: A clinical practice guideline. 2014."},{"issue":"4","key":"1612_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/09540120410001683411","volume":"16","author":"A Loughlin","year":"2004","unstructured":"Loughlin A, Metsch L, Gardner L, Anderson-Mahoney P, Barrigan M, Strathdee S. Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users. AIDS Care. 2004;16(4):485\u2013500.","journal-title":"AIDS Care."},{"issue":"46","key":"1612_CR13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","volume":"64","author":"DK Smith","year":"2015","unstructured":"Smith DK, Van Handel M, Wolitski RJ, Stryker JE, Hall HI, Prejean J, et al. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition\u2014United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1291\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"1612_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11904-010-0062-4","volume":"7","author":"K Underhill","year":"2010","unstructured":"Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV\/AIDS Rep. 2010;7(4):210\u20139.","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"9","key":"1612_CR15","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s10461-014-0778-z","volume":"18","author":"M Stein","year":"2014","unstructured":"Stein M, Thurmond P, Bailey G. Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS Behav. 2014;18(9):1694\u2013700.","journal-title":"AIDS Behav"},{"issue":"5","key":"1612_CR16","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s10461-014-0867-z","volume":"19","author":"DJ Escudero","year":"2015","unstructured":"Escudero DJ, Kerr T, Wood E, Nguyen P, Lurie MN, Sued O, et al. Acceptability of HIV pre-exposure prophylaxis (PREP) among people who inject drugs (PWID) in a canadian setting. AIDS Behav. 2015;19(5):752\u20137.","journal-title":"AIDS Behav"},{"issue":"1","key":"1612_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/cid\/civ736","volume":"62","author":"DS Krakower","year":"2016","unstructured":"Krakower DS, Beekmann SE, Polgreen PM, Mayer KH. Diffusion of newer HIV prevention innovations: variable practices of frontline infectious diseases physicians. Clin Infect Dis. 2016;62(1):99\u2013105.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1612_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/QAI.0000000000000780","volume":"70","author":"AD Castel","year":"2015","unstructured":"Castel AD, Feaster DJ, Tang W, Willis S, Jordan H, Villamizar K, et al. Understanding HIV care provider attitudes regarding intentions to prescribe PrEP. J Acquir Immune Defic Syndr. 2015;70(5):520\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"1612_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540121.2016.1153595","volume":"28","author":"LM Adams","year":"2016","unstructured":"Adams LM, Balderson BH. HIV providers\u2019 likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care. 2016;28(9):1\u20135.","journal-title":"AIDS Care."},{"key":"1612_CR20","unstructured":"The Henry J. Kaiser Family Foundation. Primary care physicians by field [5.14.2016]. 2016. Available from: \n                    http:\/\/kff.org\/other\/state-indicator\/primary-care-physicians-by-field\/\n                    \n                  ."},{"issue":"10","key":"1612_CR21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/jvh.12393","volume":"22","author":"AA Artenie","year":"2015","unstructured":"Artenie AA, Jutras-Aswad D, Roy E, Zang G, Bamvita JM, Levesque A, et al. Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement. J Viral Hepat. 2015;22(10):792\u20139.","journal-title":"J Viral Hepat."},{"issue":"9","key":"1612_CR22","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1007\/s10461-014-0839-3","volume":"18","author":"D Krakower","year":"2014","unstructured":"Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers\u2019 perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712\u201321.","journal-title":"AIDS Behav"},{"key":"1612_CR23","doi-asserted-by":"crossref","unstructured":"Blackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, et al. HIV Pre-exposure prophylaxis adoption among primary care physicians: implications for implementation. J Gen Intern Med. 2016. [Epub ahead of print].","DOI":"10.1007\/s11606-016-3903-z"},{"issue":"Suppl 1","key":"1612_CR24","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1097\/QAI.0b013e31820a9a82","volume":"56","author":"PJ Lum","year":"2011","unstructured":"Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S91\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1612_CR25","unstructured":"American Academy of HIV Medicine. Practicing HIV specialist (AAHIVS) .2016. \n                    http:\/\/www.aahivm.org\/aahivs\n                    \n                  . Accessed 17 Sept 2016"},{"issue":"1","key":"1612_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1758-2652-15-10","volume":"15","author":"RP Westergaard","year":"2012","unstructured":"Westergaard RP, Ambrose BK, Mehta SH, Kirk GD. Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers. J Int AIDS Soc. 2012;15(1):10.","journal-title":"J Int AIDS Soc."},{"issue":"5","key":"1612_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/00126334-200004150-00006","volume":"23","author":"LM Bogart","year":"2000","unstructured":"Bogart LM, Kelly JA, Catz SL, Sosman JM. Impact of medical and nonmedical factors on physician decision making for HIV\/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr. 2000;23(5):396\u2013404.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"6","key":"1612_CR28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1001\/archinte.165.6.618","volume":"165","author":"L Ding","year":"2005","unstructured":"Ding L, Landon BE, Wilson IB, Wong MD, Shapiro MF, Cleary PD. Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med. 2005;165(6):618\u201323.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1612_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/COH.0b013e328358e49e","volume":"7","author":"SD Baral","year":"2012","unstructured":"Baral SD, Stromdahl S, Beyrer C. The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs. Curr Opin HIV AIDS. 2012;7(6):563\u20138.","journal-title":"Curr Opin HIV AIDS."},{"issue":"4","key":"1612_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10461-008-9489-7","volume":"14","author":"M Malta","year":"2010","unstructured":"Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14(4):731\u201347.","journal-title":"AIDS Behav"},{"issue":"4","key":"1612_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0163278707307899","volume":"30","author":"JB VanGeest","year":"2007","unstructured":"VanGeest JB, Johnson TP, Welch VL. Methodologies for improving response rates in surveys of physicians: a systematic review. Eval Health Prof. 2007;30(4):303\u201321.","journal-title":"Eval Health Prof"},{"issue":"4","key":"1612_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/0163278711406113","volume":"34","author":"J Dykema","year":"2011","unstructured":"Dykema J, Stevenson J, Day B, Sellers SL, Bonham VL. Effects of incentives and pre notification on response rates and costs in a national web survey of physicians. Eval Health Prof. 2011;34(4):434\u201347.","journal-title":"Eval Health Prof"},{"issue":"4","key":"1612_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/0163278712458283","volume":"35","author":"CN Klabunde","year":"2012","unstructured":"Klabunde CN, Willis GB, McLeod CC, Dillman DA, Johnson TP, Greene SM, et al. Improving the quality of surveys of physicians and medical groups: a research agenda. Eval Health Prof. 2012;35(4):477\u2013506.","journal-title":"Eval Health Prof"},{"issue":"7","key":"1612_CR34","doi-asserted-by":"publisher","first-page":"e0132398","DOI":"10.1371\/journal.pone.0132398","volume":"10","author":"DS Krakower","year":"2015","unstructured":"Krakower DS, Oldenburg CE, Mitty JA, Wilson IB, Kurth AE, Maloney KM, et al. Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: results from a survey of healthcare providers in New England. PLoS ONE. 2015;10(7):e0132398.","journal-title":"PLoS ONE"},{"key":"1612_CR35","unstructured":"Mera RM, Palmer S, Mayer B, Magnuson G, RawlingsD, Truvada K (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States (2013\u20132015). International AIDS Conference:Durban 2016."},{"issue":"2","key":"1612_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ADM.0b013e31824339fc","volume":"6","author":"EJ Edelman","year":"2012","unstructured":"Edelman EJ, Dinh AT, Moore BA, Schottenfeld RS, Fiellin DA, Sullivan LE. Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians. J Addict Med. 2012;6(2):159\u201365.","journal-title":"J Addict Med."},{"issue":"11","key":"1612_CR37","doi-asserted-by":"publisher","first-page":"e112425","DOI":"10.1371\/journal.pone.0112425","volume":"9","author":"K Underhill","year":"2014","unstructured":"Underhill K, Morrow KM, Colleran CM, Holcomb R, Operario D, Calabrese SK, et al. Access to healthcare, HIV\/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS ONE. 2014;9(11):e112425.","journal-title":"PLoS ONE"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-016-1612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-016-1612-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-016-1612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T11:46:04Z","timestamp":1589715964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-016-1612-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1612"],"URL":"https:\/\/doi.org\/10.1007\/s10461-016-1612-6","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]},"assertion":[{"value":"28 November 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Fiellin has received honoraria from Pinney Associates for serving on an external advisory board monitoring the diversion and abuse of buprenorphine. The authors have no other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was reviewed and considered exempt by both Yale University and Albert Einstein College of Medicine\u2019s Humans Investigation Committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}